These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36204758)

  • 1. The impact of platform corporate venture capital vs. traditional corporate venture capital on internet initial public offering underpricing: Evidence from Chinese-listed internet firms.
    Fu F; Chen S
    Front Psychol; 2022; 13():984733. PubMed ID: 36204758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The courage to venture: Revealing the effect of social trust on corporate venture capital.
    Zhang Y; Guo X
    PLoS One; 2023; 18(12):e0295844. PubMed ID: 38134128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venture capital activities under uncertainty: US and UK investors behavior.
    Shuwaikh F; Brintte S; Khemiri S; Castro RG
    Ann Oper Res; 2022 Sep; ():1-33. PubMed ID: 36191163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financing the health care Internet.
    Robinson JC
    Health Aff (Millwood); 2000; 19(6):72-88. PubMed ID: 11192423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does venture capital cross-border syndication spur corporate innovation? Evidence from China.
    Hao H; Guo L; Dong J
    Front Psychol; 2022; 13():921168. PubMed ID: 35936306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in biopharmaceutical IPOS: 1996-2005.
    Williams DR; Young CC
    J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Did the COVID-19 pandemic (really) positively impact the IPO Market? An Analysis of information uncertainty.
    Baig AS; Chen M
    Financ Res Lett; 2022 May; 46():102372. PubMed ID: 35431676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the venture capital and private equity research: a bibliometric review and future research agenda.
    Cumming D; Kumar S; Lim WM; Pandey N
    Small Bus Econ (Dordr); 2023; 61(1):173-221. PubMed ID: 38625235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring and Analysis of Venture Capital and Corporate Fraud Based on Deep Learning.
    Zhang R; Zheng L
    Comput Intell Neurosci; 2022; 2022():4589593. PubMed ID: 35685167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does venture capital Quan Zi affect stock mispricing: Evidence from Chinese listed companies.
    Chen P; Deng L
    PLoS One; 2023; 18(4):e0281255. PubMed ID: 37053247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do executives' backgrounds matter to IPO investors? Evidence from the life science industry.
    Chok J; Qian J
    PLoS One; 2013; 8(5):e60911. PubMed ID: 23690920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualified foreign institutional investors and corporate innovation: From the perspective of corporate governance.
    Wang X; Wang W; Shi XY
    Front Psychol; 2022; 13():1005409. PubMed ID: 36467163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Cross-Shareholding Conducive to Corporate Sustainability? Evidence From the Environmental Investment of Chinese Listed Firms.
    Tian J; Cao W; Ji X
    Front Psychol; 2021; 12():789811. PubMed ID: 34803864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Venture Capital Backing Improve Disclosure Controls and Procedures? Evidence from Management's Post-IPO Disclosures.
    Cumming D; Hass LH; Myers LA; Tarsalewska M
    J Bus Ethics; 2023; 187(3):539-563. PubMed ID: 37799541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEO Overconfidence, Corporate Governance, and R&D Smoothing in Technology-Based Entrepreneurial Firms.
    Huang Y; Wang X; Li Y; Yu X
    Front Psychol; 2022; 13():944117. PubMed ID: 35910989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does media sentiment affect stock prices? Evidence from China's STAR market.
    Dong X; Xu S; Liu J; Tsai FS
    Front Psychol; 2022; 13():1040171. PubMed ID: 36533006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainability reporting and corporate financial performance of IPOs: witnessing emerging market.
    Abbas YA; Mehmood W; Ali A; Aman-Ullah A
    Environ Sci Pollut Res Int; 2023 Aug; 30(36):85508-85519. PubMed ID: 37389753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic policy uncertainty and directors and officers liability insurance: a perspective on capital market pressures.
    Xie H; Lin C
    Geneva Pap Risk Insur Issues Pract; 2023 May; ():1-31. PubMed ID: 37359234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of analyst attention on the firms' innovation paths from a life cycle perspective: Evidence from China.
    Yao J; Wang D
    Heliyon; 2023 Aug; 9(8):e18940. PubMed ID: 37636392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internal capital markets, corporate investment, and the COVID-19 pandemic: Evidence from Korean business groups.
    Lee S
    Int Rev Financ Anal; 2022 Mar; 80():102053. PubMed ID: 36536790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.